Literature DB >> 17703068

Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.

Mahendra Singh1, Lauren Cowell, Sachiko Seo, Geraldine O'Neill, Erica Golemis.   

Abstract

Upregulation of the scaffolding protein HEF1, also known as NEDD9 and Cas-L, has recently been identified as a pro-metastatic stimulus in a number of different solid tumors, and has also been strongly associated with pathogenesis of BCR-Abl-dependent tumors. As the evidence mounts for HEF1/NEDD9/Cas-L as a key player in metastatic cancer, it is timely to review the molecular regulation of HEF1/NEDD9/Cas-L. Most of the mortality associated with cancer arises from uncontrolled metastases, thus a better understanding of the properties of proteins specifically associated with promotion of this process may yield insights that improve cancer diagnosis and treatment. In this review, we summarize the extensive literature regarding HEF1/NEDD9/Cas-L expression and function in signaling relevant to cell attachment, migration, invasion, cell cycle, apoptosis, and oncogenic signal transduction. The complex function of HEF1/NEDD9/Cas-L revealed by this analysis leads us to propose a model in which alleviation of cell cycle checkpoints and acquired resistance to apoptosis is permissive for a HEF1/NEDD9/Cas-L-promoted pro-metastatic phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703068      PMCID: PMC1976382          DOI: 10.1007/s12013-007-0036-3

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  130 in total

Review 1.  Arthritis syndromes associated with human T cell lymphotropic virus type I infection.

Authors:  R M McCallum; D D Patel; J O Moore; B F Haynes
Journal:  Med Clin North Am       Date:  1997-01       Impact factor: 5.456

2.  MICAL, a novel CasL interacting molecule, associates with vimentin.

Authors:  Takahiro Suzuki; Tetsuya Nakamoto; Seishi Ogawa; Sachiko Seo; Tomoko Matsumura; Kouichi Tachibana; Chikao Morimoto; Hisamaru Hirai
Journal:  J Biol Chem       Date:  2002-02-04       Impact factor: 5.157

3.  Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest.

Authors:  M M Moasser; M Srethapakdi; K S Sachar; A J Kraker; N Rosen
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

Review 4.  Integrin signalling: a new Cas(t) of characters enters the stage.

Authors:  G M O'Neill; S J Fashena; E A Golemis
Journal:  Trends Cell Biol       Date:  2000-03       Impact factor: 20.808

5.  Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.

Authors:  S Inamoto; S Iwata; T Inamoto; S Nomura; T Sasaki; Y Urasaki; O Hosono; H Kawasaki; H Tanaka; N H Dang; C Morimoto
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

6.  Lymphocyte binding to MAdCAM-1 via alpha4beta7 integrin activates a signal transduction pathway involving tyrosine phosphorylation of paxillin and p105(Cas-L).

Authors:  Shinsuke Murata; Toshiyuki Tanaka; Masayuki Miyasaka
Journal:  Immunol Lett       Date:  2002-05-01       Impact factor: 3.685

7.  Chat, a Cas/HEF1-associated adaptor protein that integrates multiple signaling pathways.

Authors:  A Sakakibara; S Hattori
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

Review 8.  Multifaceted approach to the treatment of bcr-abl-positive leukemias.

Authors:  Michael O'Dwyer
Journal:  Oncologist       Date:  2002

9.  Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes.

Authors:  M Minegishi; K Tachibana; T Sato; S Iwata; Y Nojima; C Morimoto
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

Review 10.  Structure and function of cas-L and integrin-mediated signaling.

Authors:  Sachiko Seo; Motoshi Ichikawa; Mineo Kurokawa
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

View more
  55 in total

1.  Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells.

Authors:  Sun-Hee Kim; Dianren Xia; Sang-Wook Kim; Vijaykumar Holla; David G Menter; Raymond N Dubois
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

2.  Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation.

Authors:  Gabriela I Rozenberg; Kimberly B Monahan; Chad Torrice; James E Bear; Norman E Sharpless
Journal:  Melanoma Res       Date:  2010-10       Impact factor: 3.599

Review 3.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

4.  NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

Authors:  Yann Wallez; Peter D Mace; Elena B Pasquale; Stefan J Riedl
Journal:  Genes Cancer       Date:  2012-05

Review 5.  Cell cycle-dependent ciliogenesis and cancer.

Authors:  Olga V Plotnikova; Erica A Golemis; Elena N Pugacheva
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 6.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

7.  Mesenchymal migration as a therapeutic target in glioblastoma.

Authors:  Jessie Zhong; Andre Paul; Stewart J Kellie; Geraldine M O'Neill
Journal:  J Oncol       Date:  2010-06-21       Impact factor: 4.375

8.  NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6-dependent manner.

Authors:  Varvara K Kozyreva; Sarah L McLaughlin; Ryan H Livengood; Robin A Calkins; Laura C Kelley; Anuradha Rajulapati; Ryan J Ice; Matthew B Smolkin; Scott A Weed; Elena N Pugacheva
Journal:  Mol Cancer Res       Date:  2014-02-26       Impact factor: 5.852

9.  The CRTC1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss.

Authors:  Yan Feng; Ye Wang; Zuoyun Wang; Zhaoyuan Fang; Fei Li; Yijun Gao; Hongyan Liu; Tian Xiao; Fuming Li; Yang Zhou; Qiwei Zhai; Xiaolong Liu; Yihua Sun; Nabeel Bardeesy; Kwok-kin Wong; Haiquan Chen; Zhi-qi Xiong; Hongbin Ji
Journal:  Cancer Res       Date:  2012-10-16       Impact factor: 12.701

10.  Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component.

Authors:  Tanja Vogel; Sandra Ahrens; Nicole Büttner; Kerstin Krieglstein
Journal:  Cereb Cortex       Date:  2009-07-08       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.